(Q42078893)

16 October 2017

Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies (English)

1 reference

16 October 2017

Kemshead JT

1

1 reference

16 October 2017

Hopkins K

2

1 reference

16 October 2017

Pizer B

3

1 reference

16 October 2017

Papanastassiou V

4

1 reference

16 October 2017

Coakham H

5

1 reference

16 October 2017

Bullimore J

6

1 reference

16 October 2017

Chandler C

7

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Cancer

16 October 2017

1 reference

16 October 2017

77

1 reference

16 October 2017

12

1 reference

16 October 2017

2324-2330

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.386

16 October 2017

0 references

cites work

Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

Efflux of radiolabeled polyethylene glycols and albumin from rat brain

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

The Intracerebral Movement of Proteins Injected into Blood and Cerebrospinal Fluid of Mice

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

Determinants of tumor blood flow: a review

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

Monoclonal antibodies M340 and UJ181.4 recognize antigens associated with primitive neuroectodermal tumours/tissues

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

Pharmacokinetics and dose estimates following intrathecal administration of 131I-monoclonal antibodies for the treatment of central nervous system malignancies.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150406

Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies

17 August 2018

1 reference

12 December 2020

Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.

1 reference

12 December 2020

A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors

1 reference

12 December 2020

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report

1 reference

12 December 2020

A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.386

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

9649153

1 reference